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Abstract
Trust in government agencies plays a key role in advancing these organizations’ agendas,
influencing behaviors, and effectively implementing policies. However, few studies have
examined the extent to which individuals are aware of and trust the leading United States
agencies devoted to protecting the public’s health. Using two national samples of adoles-
cents (N = 1,125) and adults (N = 5,014), we examined demographic factors, with a focus
on vulnerable groups, as correlates of awareness of and trust in the Centers for Disease
Control and Prevention (CDC), Food and Drug Administration (FDA), and the federal gov-
ernment. From nine different weighted and adjusted logistic regression models, we found
high levels of awareness of the existence of the FDA and CDC (ranging from 55.7% for ado-
lescents’ awareness of the CDC to 94.3% for adults’ awareness of the FDA) and moderate
levels of trust (ranging from a low of 41.8% for adults’ trust in the federal government and a
high of 78.8% for adolescents’ trust of the FDA). In the adolescent and adult samples,
awareness was higher among non-Hispanic Blacks and respondents with low numeracy.
With respect to trust, few consistent demographic differences emerged. Our findings pro-
vide novel insights regarding awareness and trust in the federal government and specific
United States public health agencies. Our findings suggest groups to whom these agencies
may want to selectively communicate to enhance trust and thus facilitate their communica-
tion and regulatory agendas.
Introduction
The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administra-
tion (FDA) are two United States (US) federal agencies charged with protecting the public’s
health. Both disseminate health information through nationwide campaigns [1] and are
expected to serve as reliable and accurate sources of information. The effectiveness of these
agencies (as measured by individuals’ responsiveness and compliance with governmental
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messages and regulations) likely depends on the extent to which these agencies are perceived
as trustworthy, competent, and credible [2, 3].
A growing body of research has shown associations between trust in government and
health-related behaviors and outcomes [4]. For instance, in a study of HIV-positive adults,
individuals with higher trust in government reported greater use of health care services,
increased use of antiretroviral medications, fewer emergency room visits, and improved men-
tal and physical health [5]. Other studies have demonstrated the importance of governmental
trust with vaccination intentions and uptake [6–9]. From these studies, trust in the govern-
ment and the health information it communicates can positively impact health outcomes.
Limited research also suggests that trust in government differs by individual-level charac-
teristics. In a 2015 poll from the Pew Research Center, only 19% of Americans reported that
they trust the US federal government always or most of the time [10]. Conversely, trust in the
FDA and CDC are higher than the federal government, and in the same 2015 poll, 51% and
71% of the US population reported that they view the FDA and CDC favorably, respectively
[10]. Individuals that are White [5, 10], have lower incomes, and are older [10–12] tend to be
less trusting of the government [11, 12]. For instance, in 2015, 27% of adults between the ages
of 18 and 30 said they trusted the federal government at least most of the time, compared with
19% of those aged 30–49 and 15% of those aged 50 and older [10]. However, other studies
have shown conflicting results for race and no consistent trends by educational level [11, 12].
No studies to our knowledge have examined trust in governmental agencies among other
vulnerable populations. In the current paper, we examine predictors of awareness and trust in
two key US health agencies, the CDC and the FDA, using national samples of adolescents and
adults. Given associations between age and trust in the government, we hypothesized that trust
in the CDC and FDA would be lower among adults compared to adolescents [10–12]. More-
over, given increased knowledge about the government and politics among adults and older
adults [13], we hypothesized that adolescents would be less aware of the CDC and FDA than
adults.
Methods
Sampling
Data utilized in this research come from two separate national phone surveys administered by
the Center for Regulatory Research on Tobacco Communication (CRRTC) between Septem-
ber, 2014 and June, 2015 [14]. One survey was administered to adults over the age of 18, and a
separate, independent survey was administered to adolescents aged 13–17 years old. Both sur-
veys used random-digit dialing. The survey included questions on tobacco regulatory con-
structs, such as tobacco regulatory agency credibility. Prior to the survey, consent was required
for adults and both assent and parent/guardian consent was required for adolescents. In addi-
tion, parents/guardians of adolescents answered some brief demographic questions following
the adolescent survey. The adult sample resulted in 5,014 interviews and a weighted response
rate of 42%, calculated using American Association for Public Opinion Research (AAPOR)
Response Rate 4. The youth sample resulted in 1,125 interviews and a weighted response rate
of 66% (also calculated using AAPOR Response Rate 4). In both national samples, results are
nationally representative; for the adolescent sample, the weighted sample is nationally repre-
sentative of 13–17 year olds living in the US with cell or landline access, who could expect to
obtain consent from a guardian for a tobacco use phone survey. All procedures were approved
by the UNC Chapel Hill Institutional Review Board. For more details on the survey methodol-
ogy, please refer to Boynton et al., 2016 [14].
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Measures
Outcome variables. Outcome variables used in our study included awareness of the CDC
and FDA, trust in the CDC and FDA, and trust in the federal government. To assess aware-
ness, two questions were asked of adolescents and adults: “Have you ever heard of the. . .” fol-
lowed by an option for the CDC (stated over the phone as “the CDC or the Centers for Disease
Control and Prevention”) and an option for the FDA (stated over the phone as “the FDA or
Food and Drug Administration”). Individuals who reported having heard of the CDC or the
FDA were then asked, “In your opinion, does the (CDC or FDA) give trustworthy information
to the public?” For all four items, participants were instructed to respond “yes” or “no”.
Before the main study was conducted, we used cognitive interviewing to determine if adoles-
cents and adults understood these outcome variables; no problems were reported. Since a large
proportion of respondents reported uncertainty regarding their trust in the CDC or FDA (rang-
ing from 13% to 21% of adolescents and adults), we also analyzed results with a separate category
for individuals who reported uncertainty (i.e., “don’t know” or “not sure”). The results from
these multinomial models did not qualitatively differ from the logistic regression in which uncer-
tain responses were combined with “no”. Therefore, since it was of direct interest to examine
predictors associated with trust, we combined the uncertain responses with the “no” responses
and employed a multivariable logistic regression approach.
For trust in the federal government, only adults were asked, “How much trust do you have
in the federal government?”. We categorized responses as “high trust” (i.e., respondents who
answered “a great deal” or “a fair amount of trust”) or “low trust” (i.e., respondents who
answered “not very much”, “none at all”, or “no opinion”).
Education. For education, participants were asked of their highest degree of schooling,
with categories created for: “high school degree or less”, and “greater than a high school
degree”. For adolescents, this same question was asked directly to parents.
Numeracy. Numeracy (i.e., mathematical literacy) has been shown to be associated with
medical decision making and evaluations of risk communication [15] and is related to racial
and demographic disparities in health outcomes [16]. To assess numeracy, adults and adoles-
cents were asked, “In general, which of these numbers shows the biggest risk of getting a dis-
ease?”. Participants who answered “one in 10” (the correct answer) were classified as having
high numeracy; all others were classified as having low numeracy [17].
Census region. Participants were classified as belonging to one of four census regions: the
Northeast, the Midwest, the South, and the West [18].
Current cigarette use. Previous research has demonstrated lower levels of trust among
cigarette smokers in sources of health information [19]. In addition, both the CDC and FDA
communicate about tobacco use, which is the leading cause of preventable death in the US
and worldwide [20]. Two of their most prominent and current campaigns are the CDC’s Tips
From Former Smokers campaign and the FDA’s The Real Cost. For these reasons, we assessed
current cigarette smoking as a predictor of awareness and trust.
Adult participants were asked, “Have you smoked at least 100 cigarettes in your entire life?”
and “Do you now smoke cigarettes every day, some days, or not at all?”. Participants who
reported smoking at least 100 cigarettes in their lifetime and reported smoking cigarettes every
day or some days were classified as current cigarette users. Adolescents who reported ever try-
ing a cigarette and reported using at least one cigarette in the past 30 days were categorized as
current cigarette users.
Sexual orientation. Adults were asked to identify their sexual orientation and adolescents
were asked to describe how they were sexually attracted to other people. For both adults and
adolescents, responses for gay, lesbian, and bisexual (“GLB”) were combined.
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Poverty status. For adults, poverty status was classified as above or below the 2014 pov-
erty line.
Data analysis
Analyses for this study were conducted with SAS version 9.3 [21]. Sampling weights were used
to account for the complex survey design. Descriptive analyses and cross-tabulations were
used to generate weighted percentages and confidence intervals of independent and dependent
variables. For awareness and trust in CDC, FDA, and the federal government, we conducted
nine separate multivariable logistic regression models (4 models for awareness of the CDC and
FDA; 5 models for trust of the CDC, FDA, and federal government). In each case, the reference
group included individuals who reported not being aware of or not trusting the CDC, FDA, or
federal government. Results from the logistic regression models included weighted percent-
ages, adjusted odds ratios (aOR) and confidence intervals (CI). For all analyses, statistical sig-
nificance was set at p< 0.05.
Results
Demographic characteristics
Table 1 provides weighted percentages for our sample of adolescents (N = 1,215) and adults
(N = 5,014). For both samples, approximately half of the participants were female (48.7% and
51.5%), and majority White non-Hispanic (68.9% and 62.1%) and straight or heterosexual
(96.1% and 96.8%). Most parents of adolescents reported having a high school degree or
greater (80%), as did adults (57.4%). The average ages of adolescents and adults were 15 years
and 46.7 years, respectively. Approximately one sixth of adults reported being a current
smoker (17.8%), while 3% of adolescents reported being a current smoker. Lastly, approxi-
mately one-third of adolescents and adults were classified as having low numeracy (27% and
31.9%).
Among adults, awareness of CDC and FDA was high (83.6% and 94.3%, respectively) while
moderate awareness existed among adolescents (55.8% and 81.9%, respectively) (Fig 1). Ado-
lescents reported high levels of trust in the CDC and FDA (72.2% reported trusting the CDC
and 78.8% reported trusting the FDA), while adults reported moderate levels of trust (64.6%
reported trusting the CDC and 62.5% reported trusting the FDA). Lastly, adults reported
higher trust in CDC and FDA than the federal government (42.9% reported high trust in the
federal government).
Associations for awareness of the CDC and FDA
A full description of the weighted logistic regression results for awareness of the CDC and
FDA can be seen in Table 2 and S1 File. For brevity, key results are summarized below. Across
both adolescents and adults, being Black non-Hispanic (compared to White non-Hispanic)
and having low numeracy (compared to high numeracy) were significantly associated with
lower odds of awareness of the CDC and FDA.
For adolescents only, greater odds of awareness in the CDC and FDA occurred for males,
with increasing age, and adolescents living in the South, compared to adolescents living in the
Northeast. For adults only, lower odds of awareness of the CDC and FDA occurred for His-
panic and other non-Hispanic adults, adults with a high school degree or less, adults whose
income fell below the poverty line, and young adults between the ages of 18 and 25, compared
to their counterparts. Lastly, adults identifying as GLB had greater odds of awareness of the
CDC, than adults identifying as straight or heterosexual.
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Associations for trust in the CDC and FDA
A full description of the weighted logistic regression results for trust in the CDC and FDA
among adolescents and adults can be seen in Table 3 and S2 File. Overall, few covariates were
consistently associated with trust across adolescents and adults. Among adolescents, identify-
ing as Black non-Hispanic was associated with lower odds of trusting the CDC than identifying
as White non-Hispanic. For adolescents’ trust in the FDA, individuals of older ages showed
higher odds of trusting the FDA; conversely, individuals identifying as Hispanic (compared to
Table 1. Weighted percentages for independent variables from national phone surveys administered by the Center for Regulatory Research on
Tobacco Communication in 2014–2015, stratified by adults (N = 5,014) and adolescents (N = 1,125).
Variable All adults, n (weighted %) or mean (standard
deviation)
All adolescents, n (weighted %) or mean (standard
deviation)
Gender
Female 2372 (48.52) 564 (48.66)
Male 2640 (51.48) 561 (51.34)
Age, continuous 46.73 (0.48) 15.02 (0.04)
Age, dichotomizeda
26+ years 4205 (85.1)
18–25 years 809 (14.9)
Race
White non-Hispanic 3280 (62.06) 857 (68.90)
Black non-Hispanic 948 (17.74) 114 (12.52)
Other non-Hispanic 328 (5.90) 68 (8.73)
Hispanic 432 (14.30) 84 (9.84)
Education (or parent’s
educationb)
More than high school 3241 (57.42) 879 (79.95)
High school or less 1756 (42.58) 244 (20.05)
Sexual Orientation
Straight or heterosexual 192 (3.2) 42 (3.93)
GLB 4730 (96.8) 1041 (96.07)
Numeracy
High 3401 (68.09) 818 (72.97)
Low 1599 (31.91) 307 (27.03)
Smoking Status
Not a current smoker 1151 (17.79) 40 (3.03)
Current smoker 3856 (82.21) 1085 (96.97)
Census Region
Northeast 537 (18.25) 153 (17.17)
Midwest 972 (21.53) 282 (21.55)
South 2685 (37.11) 550 (37.63)
West 819 (23.11) 139 (23.65)
Poverty Statusc
Above poverty line 3772 (82.53)
Below poverty line 868 (17.47)
Abbreviation: Gay, Lesbian, or Bisexual (GLB).
a Age was dichotomized for adults only (to compare young adults between the ages of 18–25 and adults over the age of 25).
b Adolescents’ parents were asked to report their education.
c Poverty status was not assessed in the adolescent sample.
https://doi.org/10.1371/journal.pone.0177546.t001
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non-Hispanic White individuals) and current smokers showed lower odds of trusting the
FDA.
For adults’ trust in the CDC, individuals identifying as Black non-Hispanic showed lower
odds of trusting the CDC compared to individuals identifying as White non-Hispanic. Addi-
tionally, adults with a high school degree or less and current smokers had lower odds of trust-
ing the CDC, while young adults between the ages of 18 and 25 showed greater odds of
trusting the CDC, compared to adults over the age of 25. Lastly, for adults’ trust in the FDA
only, adults whose income fell below the poverty line had higher odds of trusting agency than
adults whose income fell above the poverty line.
Associations for trust in federal government
A full description of the logistic regression results for trust in the federal government among
adults can be seen in Table 3 and S3 File. Men, Black non-Hispanic, and other non-Hispanic
adults (compared to White non-Hispanic adults) had higher odds of trusting the federal gov-
ernment; current smokers had lower odds of trusting the federal government.
Fig 1. Weighted frequencies of key dependent variables, stratified by adults and youth. Percentage of adults and
adolescents who report being aware of or trusting the CDC, FDA, and federal government.
https://doi.org/10.1371/journal.pone.0177546.g001
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Discussion
This is the first nationally representative study examining awareness and trust of the FDA and
CDC among adolescents and adults. We found high awareness of CDC and FDA among adults
Table 2. Weighted logistic regression results comparing participants who reported awareness vs. participants who did not report awareness of
the CDC and FDA from national phone surveys administered by the Center for Regulatory research on Tobacco Communication in 2014–2015.
Variable Adolescents’ Awareness of
CDC, N = 1,079
Adolescents’ Awareness of
FDA, N = 1,079
Adults’ Awareness of
CDC, N = 4,540
Adults’ Awareness of
FDA, N = 4,540
aOR (95% CI) aOR (95% CI) aOR (95% CI) aOR (95% CI)
Gender
Female REF REF REF REF
Male 1.60 (1.20–2.14)* 1.84 (1.24–2.73)* 0.90 (0.65–1.24) 0.96 (0.53–1.74)
Age, continuous 1.67 (1.50–1.87)* 1.94 (1.65–2.29)*
Age, dichotomizeda
26+ years REF REF REF REF
18–25 years 0.52 (0.36, 0.75)* 0.42 (0.22, 0.79)*
Race
White non-Hispanic REF REF REF REF
Black non-Hispanic 0.45 (0.28–0.71)* 0.39 (0.22–0.67)* 0.44 (0.30–0.65)* 0.27 (0.14–0.55)*
Other non-Hispanic 1.22 (0.70–2.14) 1.14 (0.54–2.41) 0.32 (0.18–0.56)* 0.29 (0.12–0.71)*
Hispanic 1.15 (0.66–2.00) 0.58 (0.29–1.15) 0.21 (0.14–0.31)* 0.14 (0.07–0.30)*
Education (or parent’s
educationb)
More than high school REF REF REF REF
High school or less 0.75 (0.53–1.08) 0.45 (0.29–1.15) 0.31 (0.22–0.43)* 0.21 (0.12–0.37)*
Sexual Orientation
Straight or
heterosexual
REF REF REF REF
GLB 2.28 (0.99–5.26) 2.06 (0.46–9.23) 2.15 (1.04–4.44)* 0.49 (0.22–1.10)
Numeracy
High REF REF REF REF
Low 0.39 (0.28–0.53)* 0.34 (0.22–0.51)* 0.61 (0.44–0.84)* 0.45 (0.25–0.78)*
Smoking Status
Not a current smoker REF REF REF REF
Current smoker 0.57 (0.23–1.41) 3.52 (0.77–16.02) 0.94 (0.65–1.38) 1.11 (0.58–2.13)
Census Region
Northeast REF REF REF REF
Midwest 0.63 (0.40–1.01) 0.83 (0.41–1.69) 0.78 (0.44–1.38) 0.35 (0.14–0.84)*
South 0.84 (0.54–1.29) 0.67 (0.35–1.27) 0.98 (0.61–1.58) 0.68 (0.30–1.53)
West 0.33 (0.20–0.57)* 0.35 (0.17–0.74)* 0.83 (0.49–1.39) 0.55 (0.23–1.35)
Poverty Statusc
Above poverty line REF REF
Below poverty line 0.64 (0.44–0.92)* 0.51 (0.28–0.93)*
Abbreviations: Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), Referent Group (REF), Gay, Lesbian, or Bisexual
(GLB), Adjusted Odds Ratio (aOR), Confidence Interval (CI).
a Age was dichotomized for adults only (to compare young adults between the ages of 18–25 and adults over the age of 25).
b Adolescents’ parents were asked to report their education.
c Poverty status was not assessed in the adolescent sample.
* p 05.
https://doi.org/10.1371/journal.pone.0177546.t002
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Table 3. Weighted logistic regression results comparing participants who reported trust vs. participants who did not report trust of the CDC, FDA,
and federal government from national phone surveys administered by the Center for Regulatory research on Tobacco Communication in 2014–
2015d.
Variable Adolescents’ Trust in
CDC, N = 632
Adolescents’ Trust in
FDA, N = 905
Adults’ Trust in
CDC, N = 3,867
Adults’ Trust in
FDA, N = 4326
Adults’ Trust in Federal
Gov’t, N = 4526
aOR (95% CI) aOR (95% CI) aOR (95% CI) aOR (95% CI) aOR (95% CI)
Gender
Female REF REF REF REF REF
Male 1.19 (0.80–1.77) 1.00 (0.70–1.44) 1.12 (0.87–1.43) 1.00 (0.80–1.25) 1.32 (1.06–1.65)*
Age, continuous 1.04 (0.90–1.19) 1.17 (1.02–1.35)*
Age, dichotomizeda
26+ years REF REF REF
18–25 years 1.46 (1.02, 2.09)* 1.25 (0.92, 1.68) 0.83 (0.63, 1.09)
Race
White non-Hispanic REF REF REF REF REF
Black non-Hispanic 0.51 (0.27–0.96)* 0.77 (0.41–1.45) 0.69 (0.48–0.99)* 0.76 (0.55–1.05) 1.59 (1.17–2.15)*
Other non-Hispanic 0.64 (0.30–1.35) 1.05 (0.49–2.27) 0.78 (0.51–1.20) 0.88 (0.59–1.31) 1.53 (1.05–2.23)*
Hispanic 1.00 (0.47–2.15) 0.46 (0.24–0.86)* 0.71 (0.48–1.04) 0.79 (0.55–1.13) 1.27 (0.90–1.78)
Education (or parent’s
educationb)
More than high school REF REF REF REF REF
High school or less 0.79 (0.50–1.25) 0.83 (0.52–1.31) 0.64 (0.48–0.86)* 0.96 (0.74–1.25) 0.83 (0.66–1.06)
Sexual Orientation
Straight or
heterosexual
REF REF REF REF REF
GLB 1.19 (0.44–3.21) 0.78 (0.33–1.82) 1.24 (0.72–2.15) 1.06 (0.64–1.73) 1.22 (0.78–1.89)
Numeracy
High REF REF REF REF REF
Low 1.31 (0.77–2.23) 0.89 (0.58–1.37) 0.87 (0.68–1.14) 0.86 (0.68–1.09) 0.84 (0.66–1.06)
Smoking Status
Not a current smoker REF REF REF REF REF
Current smoker 0.45 (0.17–1.16) 0.30 (0.14–0.64)* 0.68 (0.51–0.92)* 0.81 (0.62–1.06) 0.52 (0.40–0.68)*
Census Region
Northeast REF REF REF REF REF
Midwest 0.90 (0.49–1.66) 1.26 (0.71–2.23) 0.86 (0.56–1.32) 0.95 (0.65–1.40) 0.81 (0.56–1.18)
South 0.82 (0.47–1.42) 1.13 (0.66–1.88) 0.92 (0.64–1.33) 0.96 (0.69–1.34) 0.82 (0.59–1.13)
West 0.84 (0.40–1.75) 1.27 (0.65–2.50) 0.96 (0.65–1.42) 0.88 (0.62–1.25) 0.82 (0.58–1.15)
Poverty Statusc
Above poverty line REF REF REF
Below poverty line 1.42 (0.96–2.11) 1.40 (1.02–1.93)* 1.30 (0.93–1.79)
Abbreviations: Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), Referent Group (REF), Gay, Lesbian, or Bisexual
(GLB), Adjusted Odds Ratio (aOR), Confidence Interval (CI).
a Age was dichotomized for adults only (to compare young adults between the ages of 18–25 and adults over the age of 25).
b Adolescents’ parents were asked to report their education.
c Poverty status was not assessed in the adolescent sample.
d Only participants who reported that they were aware of the CDC or FDA were asked questions to assess if they found these agencies to be trustworthy.
For this reason, sample sizes are lower and more variable.
* p 05.
https://doi.org/10.1371/journal.pone.0177546.t003
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and moderate awareness among adolescents. Conversely, we found high levels of trust in the
CDC and FDA among adolescents, but only moderate levels of trust in the CDC and FDA and
even lower levels of trust in the federal government among adults. We also found that demo-
graphic factors predicted awareness (and to a lesser extent, trust) of the CDC and FDA.
Previous research has established the importance of trust in the government as a predictor
of a wide variety of health behaviors and outcomes [4–9]. For instance, during the 2009 H1N1
(i.e., “swine flu”) outbreak, individuals who reported less confidence in the government
were less likely to take the vaccine, which resulted in a large amount of unused vaccines
[12]. Additionally, in a study of HPV vaccine acceptance, mothers who reported high trust
in the government were more likely to accept the vaccine [22]. Moreover, in a recent study
examining public support for increasing the minimum age of tobacco product sales, Lee
and colleagues found that trust in government was significantly associated with policy sup-
port, after controlling for a wide variety of demographic factors [23]. Given the association
of trust in government with several different health outcomes, continued research regarding
trust in government is important.
Few studies have looked specifically at trust in the CDC and FDA. Using nationally repre-
sentative data, we found moderate to high levels of trust in the CDC and FDA (ranging from a
low of 62% for adult trust in FDA to a high of 79% for adolescent trust in the FDA), which is
fairly consistent with a Pew Research study finding 65% of adults trust the FDA and 75% of
adults trust the CDC) [24]. We also found that few sociodemographic variables were consis-
tently significantly associated with trust in the CDC or FDA. Given that previous research has
shown associations between trust in government and health behaviors and outcomes—includ-
ing vaccine use, health care utilization, and mental and physical health [4–9]—our finding of
consistent reports of trust in CDC, FDA, and the federal government among different vulnera-
ble populations is promising. However, these agencies could seek to increase their trust among
groups who are less likely to trust them. For instance, smokers, individuals of lower education,
adults (compared to adolescents), and racial and ethnic minorities all might benefit from com-
munications from the CDC or FDA that highlight the significant work these agencies are
doing to protect public health for vulnerable groups. It is feasible (and perhaps likely) that indi-
viduals who do not trust the CDC or FDA or who are unware of the CDC or FDA may be less
likely to engage in preventive services (e.g., cancer screenings, flu shots) or follow recommen-
dations put forth by these agencies [25]. One prior study found that parents who trusted FDA
recommendations against administering over-the-counter cold medicines to young children
were more likely to follow these recommendations to protect the health of their children [25].
Moreover, these issues may be more pronounced for adolescents or vulnerable populations.
For instance, youth who do not trust the FDA may be less likely to believe campaign messages
from the Real Cost about smoking. Or African American women who do not trust the CDC or
information from the CDC may be less likely to believe that they should take actions to lower
their breast or ovarian cancer risk.
A growing body of literature suggests that agencies can use several approaches to increase
their level of trust, including faster responses to public health issues, greater transparency, and
collaboration between different public health agencies. For example, in the 2014 Ebola outbreak,
perceptions of the CDC’s response as slow and inconsistent, in conjunction with distinct health
policies adopted by the state and federal governments, diminished adults’ confidence in the
CDC and state public health agencies [26]. In another case, the FDA and CDC released conflict-
ing statements and recommendations to the public about the use and efficacy of Tamiflu, a flu
medication. As both the FDA and CDC are federal agencies, and presumed to present a united
front on health issues, the contrasting messages diminished the public’s trust in both agencies
[27]. On the other hand, after the 2001, anthrax outbreak, individuals reported high public trust
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in the CDC and its public health officials, thereby demonstrating that trust in governmental
agencies can also be enhanced [28].
Almost no studies to our knowledge have examined national awareness of the CDC or
FDA. Specifically, our findings suggest 1) high awareness of the CDC and FDA among adults
and moderate awareness among adolescents and 2) that younger individuals, African Ameri-
cans, adults with lower reported education, and individuals with low numeracy were less
aware of the CDC and FDA compared to their counterparts. One study examining racial dif-
ferences in health numeracy found that Whites, African Americans, and Hispanics with low
health numeracy were less likely to be aware of CDC than those with high health numeracy
[29]. In the same study, awareness of the CDC was one of the most important factors influenc-
ing health disparities between Whites and Hispanics in terms of health numeracy [29]. Simi-
larly, in our study, we found that adolescents and adults with low numeracy were consistently
less likely to be aware of CDC and FDA than those with high numeracy, independent of and in
addition to racial / ethnic minorities and individuals with lower education. These findings
point to a segment of the population to target to increase awareness (and hopefully subse-
quently trust) for the missions of the FDA and CDC.
Moreover, as expected, we found high awareness of the CDC and FDA among adults, but
only moderate trust in the CDC, FDA, and federal government, compared to adolescents. This is
consistent with some past research that has found greater trust in federal agencies among youn-
ger age groups [24]. There are several reasons why adults and older adults in particular may have
lower trust in the government and governmental institutions. In a study examining Australians’
trust in federal, state, and local government, researchers found that as age increased, respondents
were less likely to trust both state and federal government, with the lowest level of trust among
respondents aged 60+ [30]. The authors of this study suggested that older Australians were more
disadvantaged in terms of job opportunities, were subjected to ageism, and had limited access to
public services, all of which could be linked to government initiatives [30]. Older adults may also
be more likely to consume media containing critical information about the government [30]. In
the US, confidence in government institutions is also influenced by generation status (in addi-
tion to age). Baby boomers (born between 1946 and 1964, aged in their 50 to 67 years old in this
study) consistently have the lowest amount of trust in the government, compared to those born
before and after [31]. Researchers have argued that this phenomenon may be linked to economic
conditions (i.e., rising income inequality), which can negatively affect social capital and trust in
government institutions [31]. Future research could tease apart the extent to which trust differ-
ences between younger and older adults are due to a cohort effects, period effects, or age effects,
as there is some evidence for each of these explanations.
Finally, we have reason to believe that trust in the CDC and FDA are important variables
for future studies to examine. Literature on source credibility suggests that messages with
more credible sources are more likely to be impactful than messages with non-credible sources
(e.g., tobacco companies) or no source [32]. In an experiment manipulating message source
and content, researchers found that source was an influential variable in determining perceived
effectiveness for messages about health consequences of smoking [33]. Moreover, they found
that perceptions of credibility mediated the effect of source on ad perceived effectiveness for
some sub-populations (e.g., nonsmokers, but not smokers). From these findings, we may expect
that trust in the CDC or FDA may influence the relative success of public health campaigns;
however, it is also plausible that these patterns may differ for vulnerable populations, for whom
we found lower trust of CDC and FDA. Further research exploring how trust in the CDC and
FDA may be associated with health outcomes and/or effectiveness of public health ad cam-
paigns is warranted. Moreover, specifically among adolescents, future research could examine
the discrepancy between awareness of the FDA (which was high at 82%) and awareness of the
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CDC (which was moderate at 56%). It is possible that higher awareness of the FDA resulted
from specific FDA media campaigns aimed at youth (i.e., “The Real Cost”) [34, 35]. Qualitative
research may be useful in exploring this research area.
Limitations
Our study had several limitations, which suggest directions for future research. Our findings
that few variables consistently predicted trust may be due in part to the fact that the trust ques-
tions were only asked of people who were aware of the agencies; thus, responses may have
been more uniform in this reduced sample than would otherwise be found. It is possible and
even likely that individuals who are unaware of the FDA or CDC may not trust these organiza-
tions or have uncertainty regarding their trust in these organizations. To fully understand the
influences on awareness and trust of government agencies, other influences beyond individ-
ual-level predictors should be examined, including organizational factors (e.g. agency trans-
parency), media framing of government actions, and political climate.
Conclusions
Some of the key public health issues of our time—vaccines, medical devices, pharmaceutical
access and uptake, food safety, bioterrorism, tobacco use—are all issues for which trust in the
sources of messages about these issues is important. Without trust in the government or fed-
eral agencies, public confidence in government communication about the above issues may be
diminished. Understanding the factors that affect public trust in the federal government and
public health agencies is critical for dissemination of effective health messages [11, 36]. As new
research on FDA credibility is forthcoming [32], further investigation of how credibility and
trust of federal agencies influence health behaviors and outcomes is needed.
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